Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (2) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Hübner, Norbert Prof. Dr. (1) Klußmann, Enno PD Dr. (1) Landthaler, Markus Prof. Dr. (2) Leutz, Achim Prof. Dr. (1) Mathas, Stephan Dr. (12) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Patone, Giannino Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Selbach, Matthias Prof. Dr. (17) Wanker, Erich Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Janz, Martin Dr. (9) (-) Lewin, Gary Prof. Dr. (1) (-) Lusatis, Simone (1) (-) Scheidereit, Claus Prof. Dr. (2) 1999 (1) 2001 (1) 2002 (3) 2003 (3) 2004 (2) (-) 2005 (2) (-) 2006 (4) 2007 (2) (-) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (3) 2015 (3) (-) 2016 (3) 2017 (4) 2018 (2) 2019 (1) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) AG Müller/Dechend (ECRC) (1) (-) Biology of Malignant Lymphomas (10) Developmental Neurobiology (1) Genetics and Genomics of Cardiovascular Diseases (2) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Immune Regulation and Cancer (1) Molecular Physiology of Somatic Sensation (12) Myology (1) Nephrology and Inflammatory Vascular Diseases (1) (-) Proteome Dynamics (1) 11 Results: Active Filter: Janz, Martin Dr.Lewin, Gary Prof. Dr.Lusatis, SimoneScheidereit, Claus Prof. Dr.Biology of Malignant LymphomasProteome Dynamics2005200620082016 Sort: Result score Newest to oldest Oldest to newest October 11, 2016 / Cell Rep Hypofunctional TrkA accounts for the absence of pain sensitization in the African naked mole-rat D. Omerbašić E.S.J. Smith M. Moroni J. Homfeld O. Eigenbrod N.C. Bennett J. Reznick C.G. Faulkes M. Selbach G.R. Lewin March 17, 2016 / Genome Med A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses K.A.P. de Oliveira E. Kaergel M. Heinig J.F. Fontaine G. Patone E.M. Muro S. Mathas M. Hummel M.A. Andrade-Navarro N. Hübner C. Scheidereit May 03, 2016 / Proc Natl Acad Sci U S A Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells E. Derudder S. Herzog V. Labi T. Yasuda K. Köchert M. Janz A. Villunger M. Schmidt-Supprian K. Rajewsky August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas October 15, 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas Pagination Current page 1 Page 2 Next page Next › Last page Last »
October 11, 2016 / Cell Rep Hypofunctional TrkA accounts for the absence of pain sensitization in the African naked mole-rat D. Omerbašić E.S.J. Smith M. Moroni J. Homfeld O. Eigenbrod N.C. Bennett J. Reznick C.G. Faulkes M. Selbach G.R. Lewin
March 17, 2016 / Genome Med A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses K.A.P. de Oliveira E. Kaergel M. Heinig J.F. Fontaine G. Patone E.M. Muro S. Mathas M. Hummel M.A. Andrade-Navarro N. Hübner C. Scheidereit
May 03, 2016 / Proc Natl Acad Sci U S A Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells E. Derudder S. Herzog V. Labi T. Yasuda K. Köchert M. Janz A. Villunger M. Schmidt-Supprian K. Rajewsky
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
October 15, 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas